Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma

Fig. 1

Overview of the study design for the identification of plasma EV mRNA signature as a biomarker for the prognosis of PDAC patients. PDAC: pancreatic ductal adenocarcinoma; OS: overall survival; EV: extracellular vesicles; DESeq2: a R software package for differential gene expression analysis of RNA sequencing data; absolute Log2FC: absolute Log2 fold-change; adjP: adjusted p value; ROC: receiver operating characteristic curve; AUC: Area under the curve; KM: Kaplan–Meier; UHD: University Hospital Dresden; UHH: University Hospital Heidelberg; UHE: University Hospital Erlangen

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us